Literature DB >> 11123754

Immune mechanisms in Onchocerca volvulus-mediated corneal disease (river blindness).

E Pearlman1, L R Hall.   

Abstract

Infection with the parasitic nematode Onchocerca volvulus can lead to severe visual impairment and blindness. In an effort to characterize the molecular basis for the inflammatory response in the cornea, we have developed a murine model for O. volvulus-mediated keratitis in which parasite antigens are injected into the corneal stroma of sensitized mice. This model reproduces the two main clinical features of human disease, corneal opacification and neovascularization. Histological analysis of corneas from these mice reveals a biphasic recruitment of neutrophils and eosinophils to the central cornea, along with a small, but persistent number of CD3+ cells. In this review, we present evidence that production of antigen-specific T cell and antibody responses are essential for development of O. volvulus keratitis, and we propose a sequence of molecular and cellular events that lead to migration of inflammatory cells to the cornea and to loss of corneal clarity.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11123754     DOI: 10.1046/j.1365-3024.2000.00345.x

Source DB:  PubMed          Journal:  Parasite Immunol        ISSN: 0141-9838            Impact factor:   2.280


  11 in total

Review 1.  Immunology of parasitic helminth infections.

Authors:  Andrew S MacDonald; Maria Ilma Araujo; Edward J Pearce
Journal:  Infect Immun       Date:  2002-02       Impact factor: 3.441

Review 2.  The Eosinophil in Infection.

Authors:  Karen A Ravin; Michael Loy
Journal:  Clin Rev Allergy Immunol       Date:  2016-04       Impact factor: 8.667

Review 3.  Onchocerciasis: the role of Wolbachia bacterial endosymbionts in parasite biology, disease pathogenesis, and treatment.

Authors:  Francesca Tamarozzi; Alice Halliday; Katrin Gentil; Achim Hoerauf; Eric Pearlman; Mark J Taylor
Journal:  Clin Microbiol Rev       Date:  2011-07       Impact factor: 26.132

Review 4.  Pattern recognition receptors in microbial keratitis.

Authors:  M-A Taube; M del Mar Cendra; A Elsahn; M Christodoulides; P Hossain
Journal:  Eye (Lond)       Date:  2015-07-10       Impact factor: 3.775

5.  Wolbachia-induced neutrophil activation in a mouse model of ocular onchocerciasis (river blindness).

Authors:  Illona Gillette-Ferguson; Amy G Hise; Helen F McGarry; Joseph Turner; Andrew Esposito; Yan Sun; Eugenia Diaconu; Mark J Taylor; Eric Pearlman
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

6.  Keratocan and lumican regulate neutrophil infiltration and corneal clarity in lipopolysaccharide-induced keratitis by direct interaction with CXCL1.

Authors:  Eric C Carlson; Michelle Lin; Chia-Yang Liu; Winston W-Y Kao; Victor L Perez; Eric Pearlman
Journal:  J Biol Chem       Date:  2007-10-02       Impact factor: 5.157

7.  Density-dependent mortality of the human host in onchocerciasis: relationships between microfilarial load and excess mortality.

Authors:  Martin Walker; Mark P Little; Karen S Wagner; Edoh W Soumbey-Alley; Boakye A Boatin; María-Gloria Basáñez
Journal:  PLoS Negl Trop Dis       Date:  2012-03-27

Review 8.  The Immunological Role of Vascular and Lymphatic Endothelial Cells in Filarial Infections.

Authors:  Magdalena Elżbieta Wysmołek; Ewa Długosz; Marcin Wiśniewski
Journal:  Animals (Basel)       Date:  2022-02-10       Impact factor: 2.752

Review 9.  Post-Infectious Autoimmunity in the Central (CNS) and Peripheral (PNS) Nervous Systems: An African Perspective.

Authors:  Alvin Pumelele Ndondo; Brian Eley; Jo Madeleine Wilmshurst; Angelina Kakooza-Mwesige; Maria Pia Giannoccaro; Hugh J Willison; Pedro M Rodríguez Cruz; Jeannine M Heckmann; Kathleen Bateman; Angela Vincent
Journal:  Front Immunol       Date:  2022-03-09       Impact factor: 7.561

Review 10.  Neurological manifestations in Onchocerca volvulus infection: A review.

Authors:  An Hotterbeekx; Vivian Namale Ssonko; William Oyet; Thomson Lakwo; Richard Idro
Journal:  Brain Res Bull       Date:  2018-11-17       Impact factor: 4.077

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.